Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Matoba

Showing results (111-120 of 166) with videos related to

Pageof 17
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Antithrombotic therapy for stable coronary artery disease and atrial fibrillation in patients with and without revascularisation: the AFIRE trialTakashi Noda, Kotaro Nochioka, Koichi Kaikita, et al.
Circulation Reports|November 11, 2025
Preventive Effect of Nifekalant on Recurrent Ventricular Fibrillation and Electrical Storm　- A Systematic Review and Meta-AnalysisKazuo Sakamoto, Kenichi Iijima, Tetsuma Kawaji, et al.
International Journal of Cardiology. Heart & Vasculature|September 24, 2024
Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS databaseYasuhiro Hitomi, Yasushi Imai, Masanari Kuwabara, et al.
Heart and Vessels|September 29, 2022
Clinical picture of the duration of venoarterial extracorporeal membrane oxygenation: analysis from JROAD-DPCKazuo Sakamoto, Tetsuya Matoba, Michikazu Nakai, et al.
Circulation Reports|July 12, 2023
Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in JapanYasuhiro Nakano, Tetsuya Matoba, Mitsutaka Yamamoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 10, 2022
Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition SystemYusuke Oba, Tomoyuki Kabutoya, Takahide Kohro, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|July 11, 2025
Usefulness of the AHEAD score for prediction of all-cause death in patients with acute and chronic coronary syndromesShunsuke Tamaki, Akinori Higaki, Hiroshi Kawakami, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2025
Activated Factor X Inhibition Ameliorates NF-κB-IL-6‒Mediated Perivascular Inflammation and Pulmonary HypertensionSatomi Imakiire, Keiji Kimuro, Keimei Yoshida, et al.
Journal of Cardiology|April 12, 2025
Effect of PCSK9 inhibitor usage on coronary endothelial dysfunction in patients with hypercholesterolemia after coronary stenting: The CuVIC-2 trialYusuke Akiyama, Shunsuke Katsuki, Yasuaki Koga, et al.
Diabetes|October 7, 2022
Identifying Hyperreflective Foci in Diabetic Retinopathy via VEGF-Induced Local Self-Renewal of CX3CR1+ Vitreous Resident MacrophagesMuneo Yamaguchi, Shintaro Nakao, Iori Wada, et al.
Pageof 17

Showing results (111-120 of 166) with videos related to

Sort By:
Pageof 17
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|April 2, 2024
Antithrombotic therapy for stable coronary artery disease and atrial fibrillation in patients with and without revascularisation: the AFIRE trialTakashi Noda, Kotaro Nochioka, Koichi Kaikita, et al.
Circulation Reports|November 11, 2025
Preventive Effect of Nifekalant on Recurrent Ventricular Fibrillation and Electrical Storm　- A Systematic Review and Meta-AnalysisKazuo Sakamoto, Kenichi Iijima, Tetsuma Kawaji, et al.
International Journal of Cardiology. Heart & Vasculature|September 24, 2024
Relationship between the number of drugs used during percutaneous coronary intervention and adverse events in patients with chronic coronary syndrome: Analysis of CLIDAS databaseYasuhiro Hitomi, Yasushi Imai, Masanari Kuwabara, et al.
Heart and Vessels|September 29, 2022
Clinical picture of the duration of venoarterial extracorporeal membrane oxygenation: analysis from JROAD-DPCKazuo Sakamoto, Tetsuya Matoba, Michikazu Nakai, et al.
Circulation Reports|July 12, 2023
Temporal Trends in Antithrombotic Therapy for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention From 2014 to 2022 in JapanYasuhiro Nakano, Tetsuya Matoba, Mitsutaka Yamamoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|October 10, 2022
Relationships Among Heart Rate, β-Blocker Dosage, and Prognosis in Patients With Coronary Artery Disease in a Real-World Database Using a Multimodal Data Acquisition SystemYusuke Oba, Tomoyuki Kabutoya, Takahide Kohro, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|July 11, 2025
Usefulness of the AHEAD score for prediction of all-cause death in patients with acute and chronic coronary syndromesShunsuke Tamaki, Akinori Higaki, Hiroshi Kawakami, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|June 13, 2025
Activated Factor X Inhibition Ameliorates NF-κB-IL-6‒Mediated Perivascular Inflammation and Pulmonary HypertensionSatomi Imakiire, Keiji Kimuro, Keimei Yoshida, et al.
Journal of Cardiology|April 12, 2025
Effect of PCSK9 inhibitor usage on coronary endothelial dysfunction in patients with hypercholesterolemia after coronary stenting: The CuVIC-2 trialYusuke Akiyama, Shunsuke Katsuki, Yasuaki Koga, et al.
Diabetes|October 7, 2022
Identifying Hyperreflective Foci in Diabetic Retinopathy via VEGF-Induced Local Self-Renewal of CX3CR1+ Vitreous Resident MacrophagesMuneo Yamaguchi, Shintaro Nakao, Iori Wada, et al.
Pageof 17